MA57032B2 - Utilisation de beige cas9 issu de bactérie pasteurella pneumotropica - Google Patents

Utilisation de beige cas9 issu de bactérie pasteurella pneumotropica

Info

Publication number
MA57032B2
MA57032B2 MA57032A MA57032A MA57032B2 MA 57032 B2 MA57032 B2 MA 57032B2 MA 57032 A MA57032 A MA 57032A MA 57032 A MA57032 A MA 57032A MA 57032 B2 MA57032 B2 MA 57032B2
Authority
MA
Morocco
Prior art keywords
cas9
beige
bacteria
crispr
nuclease
Prior art date
Application number
MA57032A
Other languages
English (en)
Other versions
MA57032A1 (fr
Inventor
Timofey Aleksandrovich Nemankin
Roman Alekseevich IVANOV
Pavel Andreevich IAKOVLEV
Anna Konstantinovna VLADIMIROVA
Dmitry Valentinovich MOROZOV
Sergey Anatolievich Lukyanov
Konstantin Viktorovich SEVERINOV
Arina Vitalevna ANIKINA
Mariia Aleksandrovna SHCHEMELEVA
Alexey Konstantinovich MISORIN
Dmitry Borisovich STAROVEROV
Anna Valentinovna EVSTRATEVA
Original Assignee
Joint Stock Company "Biocad"
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Joint Stock Company "Biocad" filed Critical Joint Stock Company "Biocad"
Publication of MA57032A1 publication Critical patent/MA57032A1/fr
Publication of MA57032B2 publication Critical patent/MA57032B2/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/102—Mutagenizing nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/22—Ribonucleases [RNase]; Deoxyribonucleases [DNase]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6806—Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/20—Type of nucleic acid involving clustered regularly interspaced short palindromic repeats [CRISPR]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y301/00—Hydrolases acting on ester bonds (3.1)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

La présente invention concerne une nouvelle nucléase bactérienne du système CRISPR-Cas9 à partir de la bactérie P. pneumotropica, ainsi que son utilisation pour former des ruptures strictement spécifiques à deux brins dans la molécule d'ADN. Cette nucléase possède des propriétés inhabituelles et peut être utilisée afin de modifier la séquence de l'ADN génomique dans la cellule d'un organisme monocellulaire ou pluricellulaire Il est ainsi possible d'améliorer l'universalité de systèmes disponibles CRISPR-Cas9, ce qui permet d'utiliser différentes variantes de nucléases Cas9 pour découper l'ADN génomique ou plasmidique dans divers organismes et dans une grande quantité de sites spécifiques et/ou dans diverses conditions.
MA57032A 2019-11-11 2020-07-02 Utilisation de beige cas9 issu de bactérie pasteurella pneumotropica MA57032B2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
RU2019136164A RU2724470C1 (ru) 2019-11-11 2019-11-11 Применение cas9 белка из бактерии pasteurella pneumotropica для модификации геномной днк в клетках
PCT/RU2020/050145 WO2021096391A1 (fr) 2019-11-11 2020-07-02 Utilisation de beige cas9 issu de bactérie pasteurella pneumotropica

Publications (2)

Publication Number Publication Date
MA57032A1 MA57032A1 (fr) 2023-01-31
MA57032B2 true MA57032B2 (fr) 2024-11-29

Family

ID=71136150

Family Applications (1)

Application Number Title Priority Date Filing Date
MA57032A MA57032B2 (fr) 2019-11-11 2020-07-02 Utilisation de beige cas9 issu de bactérie pasteurella pneumotropica

Country Status (17)

Country Link
US (1) US20220403369A1 (fr)
EP (1) EP4056705A4 (fr)
JP (1) JP7708752B2 (fr)
KR (1) KR20220145324A (fr)
CN (1) CN115397995B (fr)
AU (1) AU2020384851A1 (fr)
BR (1) BR112022009148A2 (fr)
CA (1) CA3157898A1 (fr)
CL (1) CL2022001220A1 (fr)
CO (1) CO2022006156A2 (fr)
MA (1) MA57032B2 (fr)
MX (1) MX2022005685A (fr)
PE (1) PE20230035A1 (fr)
PH (1) PH12022551155A1 (fr)
RU (1) RU2724470C1 (fr)
WO (1) WO2021096391A1 (fr)
ZA (1) ZA202205208B (fr)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MA55390B1 (fr) * 2019-04-23 2022-10-31 Biocad Joint Stock Co Dispositif pour découper l'adn à base de la protéine cas9 à partir de la bactérie pasteurella pneumotropica

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112020554B (zh) * 2018-02-23 2024-10-22 先锋国际良种公司 新颖cas9直系同源物
WO2021178709A1 (fr) * 2020-03-04 2021-09-10 Flagship Pioneering Innovations Vi, Llc Procédés et compositions pour moduler un génome

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MA55390B1 (fr) * 2019-04-23 2022-10-31 Biocad Joint Stock Co Dispositif pour découper l'adn à base de la protéine cas9 à partir de la bactérie pasteurella pneumotropica

Also Published As

Publication number Publication date
CL2022001220A1 (es) 2023-01-06
US20220403369A1 (en) 2022-12-22
CA3157898A1 (fr) 2021-05-20
WO2021096391A1 (fr) 2021-05-20
BR112022009148A2 (pt) 2023-05-02
ZA202205208B (en) 2023-04-26
EP4056705A1 (fr) 2022-09-14
EP4056705A4 (fr) 2023-12-27
RU2724470C1 (ru) 2020-06-23
JP7708752B2 (ja) 2025-07-15
PH12022551155A1 (en) 2023-10-02
PE20230035A1 (es) 2023-01-10
JP2023501524A (ja) 2023-01-18
KR20220145324A (ko) 2022-10-28
CN115397995A (zh) 2022-11-25
MX2022005685A (es) 2022-07-27
AU2020384851A1 (en) 2022-12-01
CN115397995B (zh) 2025-04-11
CO2022006156A2 (es) 2023-01-26
MA57032A1 (fr) 2023-01-31

Similar Documents

Publication Publication Date Title
MA55390B1 (fr) Dispositif pour découper l'adn à base de la protéine cas9 à partir de la bactérie pasteurella pneumotropica
US20260028601A1 (en) Recombinase polymerase amplification
Moran et al. Comparative genomics using Candida albicans DNA microarrays reveals absence and divergence of virulence-associated genes in Candida dubliniensis
Mendillo et al. Analysis of the interaction between the Saccharomyces cerevisiae MSH2-MSH6 and MLH1-PMS1 complexes with DNA using a reversible DNA end-blocking system
Sforza et al. Food analysis and food authentication by peptide nucleic acid (PNA)-based technologies
Chiba et al. Staphylococcus aureus utilizes environmental RNA as a building material in specific polysaccharide-dependent biofilms
MA53578B1 (fr) Dispositif pour découper l'adn à base de la protéine cas9 à partir de defluviimonas sp.
Szweda et al. Mechanisms of azole resistance among clinical isolates of Candida glabrata in Poland
MA58208B1 (fr) Acides nucléiques pour inhiber l'expression de lpa dans une cellule
Turrientes et al. Polymorphic mutation frequencies of clinical and environmental Stenotrophomonas maltophilia populations
Peng et al. WalK (S221P), a naturally occurring mutation, confers vancomycin resistance in VISA strain XN108
Tone et al. Enhancing melting curve analysis for the discrimination of loop-mediated isothermal amplification products from four pathogenic molds: Use of inorganic pyrophosphatase and its effect in reducing the variance in melting temperature values
MA57032B2 (fr) Utilisation de beige cas9 issu de bactérie pasteurella pneumotropica
Roberti et al. The Drosophila termination factor DmTTF regulates in vivo mitochondrial transcription
WO2018140329A8 (fr) Méthodes de construction de copies de molécules d'acide nucléique
CA2777928C (fr) Polymorphisme genetique dans la degenerescence maculaire liee a l'age
Zhou et al. Asymmetric division yields progeny cells with distinct modes of regulating cell cycle-dependent chromosome methylation
Kornyushyna et al. Effect of the oxidized guanosine lesions spiroiminodihydantoin and guanidinohydantoin on proofreading by Escherichia coli DNA polymerase I (Klenow fragment) in different sequence contexts
Soriano-Abarca et al. Virulence-related genes expression in planktonic mixed cultures of Candida albicans and non-Albicans Candida species
Bado et al. Detection of qnrVC6, within a new genetic context, in an NDM-1-producing Citrobacter freundii clinical isolate from Uruguay
Wolter et al. Allelic variation in genes encoding Panton–Valentine leukocidin from community-associated Staphylococcus aureus
Conner et al. Forward genetic analysis of Toll-like receptor responses in wild-derived mice reveals a novel antiinflammatory role for IRAK1BP1
Charif et al. Molecular analysis of the TMPRSS3 gene in Moroccan families with non-syndromic hearing loss
MA43600A1 (fr) Anticorps trispecifique anti il-17a,il-17f et une autre molécule anti-inflammatoire
Chou et al. A novel mutation in NCF2 associated with autoimmune disease and a solitary late-onset infection